Diabetes decisions — 2026

The Board has granted readjudication of the Veteran's claims for service connection due to new and relevant evidence submitted since the June 2024 decision. The issues remain remanded.

The Veteran's diabetes mellitus is being remanded for a VA medical opinion regarding its etiology, specifically considering the PACT Act and TERA exposure. The claim will be readjudicated based on new evidence received after the August 2013 rating decision.

The Board has decided to remand the case due to a duty-to-assist error, and will require an addendum medical opinion regarding whether the Veteran's diabetes mellitus, type II was caused or aggravated by his service-connected acquired psychiatric disorder.

The Veteran's TDIU for accrued benefits purposes is granted, and the initial compensable rating for his service-connected back scar is denied. The claims of higher ratings for lumbar spine disability, bilateral lower extremity radiculopathy are remanded.

The Board denied the Veteran's claims for service connection for sleep apnea, diabetes, and fibromyalgia as secondary to PTSD due to a lack of medical evidence linking these conditions to his service-connected acquired psychiatric disorder.

The Veteran's sleep apnea and diabetes mellitus type II were not rated higher than the current assigned ratings.,Earlier effective dates for various benefits and ratings were denied.

The appeal has been dismissed due to the Veteran's death while the appeal was pending.

The Veteran's claims for cerebrovascular strokes and chronic lymphocytic leukemia (CLL) are denied as there is no evidence of a nexus between these conditions and his military service.

The Board has granted effective dates of August 10, 2022 for hypertension and July 25, 2023 for diabetes mellitus, type II, bilateral lower extremity diabetic peripheral neuropathy, a bilateral hearing loss disability, and tinnitus.,The Veteran's conditions were found to have manifested no later than the dates specified in their respective effective dates.

Service connection for diabetes mellitus Type II is granted. The Board also found that service connection should be granted for hypertension and paroxysmal atrial fibrillation as secondary to the Veteran's diabetes mellitus.

The Board has decided to remand the case due to insufficient medical opinions regarding the etiology of the Veteran's diabetes and whether his service-connected conditions caused or aggravated obesity/weight gain, which is an intermediate factor in causing diabetes.

The Veteran's appeal for service connection for diabetes mellitus type II, diabetic retinopathy, peripheral neuropathy affecting the right and left lower extremities, and urinary incontinence is dismissed. The appeal for service connection for an aortic aneurysm is also dismissed.

The Board has remanded the Veteran's claims for service connection for coronary artery disease, high blood pressure, diabetes mellitus, type II, and skin cancer due to potential exposure to Agent Orange during his military service. The AOJ is instructed to develop the record further regarding the Veteran's claimed locations prior to boarding the USS Coral Sea and obtain a medical opinion on the nature and likely etiology of the Veteran's hypertension and skin cancer.

The Board has determined that the effective dates for service connection of diabetic peripheral neuropathy in the lower extremities and hypertension are June 28, 2019.

The Board has granted the Veteran's claim for service connection for diabetes mellitus, finding that it is related to his service-connected psychiatric and right knee disabilities through obesity as an intermediate step.

The Board has granted service connection for bilateral lower extremity radiculopathy and denied service connection for type II diabetes mellitus and prostate cancer. The decision is based on the Veteran's diagnosed conditions and their relationship to his service-connected lumbar spine disability.

The Veteran's appeals for an earlier effective date and a higher rating for diabetes mellitus, type II, are dismissed as the VA Form 10182 was not filed within one year of the March 2024 rating decision.

The Veteran's claims for increased disability evaluations and effective dates have been denied. The Veteran's arteriosclerotic heart disease, diabetes mellitus, and peripheral neuropathy of the upper and lower extremities are currently rated at 60 percent, 20 percent, and varying percentages respectively.

The Board has granted the Veteran's claim for service connection for type II diabetes mellitus, finding that his service-connected left ankle disability, lumbar spine disability, cervical spine disability, left knee pain, left hip pain, and loss of use of the left big toe disabilities have caused him to become obese, which in turn led to his development of type II diabetes mellitus.

The Board has granted the Veteran's claims for service connection for hypertension, chronic lymphocytic leukemia, and diabetes mellitus type II. The Board also found that there is at least an approximate balance of evidence regarding whether the Veteran's right and left lower extremity diabetic peripheral neuropathy was caused by his now service-connected diabetes mellitus type II.